Nifty
Sensex
:
:
10891.60
36939.60
-181.85 (-1.64%)
-667.29 (-1.77%)

Pharmaceuticals & Drugs - Domestic

Rating :
74/99  (View)

BSE: 531599 | NSE: FDC

319.40
20.25 (6.77%)
03-Aug-2020 | 3:59PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  301.00
  •  325.00
  •  300.50
  •  299.15
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  3716257
  •  11869.72
  •  325.00
  •  156.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 5,110.39
  • 21.30
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 5,089.73
  • N/A
  • 3.30

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 69.24%
  • 1.84%
  • 15.16%
  • FII
  • DII
  • Others
  • 5.31%
  • 5.07%
  • 3.38%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 5.61
  • 4.17
  • 2.46

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 3.33
  • 3.08
  • -1.04

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 1.43
  • 3.01
  • -3.03

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 19.20
  • 20.92
  • 19.26

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.91
  • 3.07
  • 2.74

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 11.61
  • 13.11
  • 12.40

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Sep 19
Sep 18
Var%
Jun 19
Jun 18
Var%
Net Sales
333
271
23%
321
256
25%
346
274
26%
344
290
18%
Expenses
304
228
34%
236
200
18%
272
216
26%
265
218
22%
EBITDA
29
43
-32%
85
56
50%
74
57
29%
78
72
9%
EBIDTM
9%
16%
26%
22%
21%
21%
23%
25%
Other Income
38
14
171%
31
14
122%
17
9
94%
10
9
13%
Interest
1
0
175%
1
0
126%
1
0
156%
1
0
98%
Depreciation
9
8
18%
9
8
23%
10
9
6%
9
9
6%
PBT
57
48
19%
106
63
69%
80
57
42%
78
72
9%
Tax
1
11
-92%
32
17
91%
26
16
58%
22
23
-4%
PAT
56
36
54%
74
46
61%
54
40
35%
56
49
15%
PATM
17%
13%
23%
18%
16%
15%
16%
17%
EPS
3.27
2.13
54%
4.34
2.69
61%
3.18
2.35
35%
3.30
2.87
15%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Net Sales
1,344
1,091
1,075
1,014
994
889
846
773
711
712
632
Net Sales Growth
23%
1%
6%
2%
12%
5%
9%
9%
0%
13%
 
Cost Of Goods Sold
426
345
352
339
358
273
266
311
238
254
221
Gross Profit
918
746
723
675
636
616
580
462
473
458
411
GP Margin
68%
68%
67%
67%
64%
69%
69%
60%
67%
64%
65%
Total Expenditure
1,078
860
848
770
766
691
641
592
547
546
466
Power & Fuel Cost
-
25
22
22
23
20
18
17
14
13
11
% Of Sales
-
2%
2%
2%
2%
2%
2%
2%
2%
2%
2%
Employee Cost
-
226
217
191
176
138
122
108
99
86
69
% Of Sales
-
21%
20%
19%
18%
15%
14%
14%
14%
12%
11%
Manufacturing Exp.
-
62
59
49
36
97
89
23
70
67
61
% Of Sales
-
6%
5%
5%
4%
11%
10%
3%
10%
9%
10%
General & Admin Exp.
-
59
62
53
50
41
36
34
34
32
32
% Of Sales
-
5%
6%
5%
5%
5%
4%
4%
5%
4%
5%
Selling & Distn. Exp.
-
79
76
64
58
65
58
56
55
55
47
% Of Sales
-
7%
7%
6%
6%
7%
7%
7%
8%
8%
7%
Miscellaneous Exp.
-
64
61
52
65
56
52
43
37
40
47
% Of Sales
-
6%
6%
5%
6%
6%
6%
6%
5%
6%
4%
EBITDA
266
231
227
243
229
199
204
181
163
166
167
EBITDA Margin
20%
21%
21%
24%
23%
22%
24%
23%
23%
23%
26%
Other Income
95
43
51
50
39
46
42
46
29
28
31
Interest
3
1
1
1
1
2
3
2
1
1
1
Depreciation
37
33
35
35
34
39
25
28
18
17
16
PBT
321
240
241
258
233
204
218
198
172
175
181
Tax
80
67
67
63
63
56
83
43
38
24
31
Tax Rate
25%
28%
28%
25%
27%
27%
38%
22%
22%
14%
17%
PAT
241
172
174
188
169
148
135
155
134
151
149
PAT before Minority Interest
241
172
174
188
169
148
135
155
134
151
149
Minority Interest
0
0
0
0
0
0
0
0
0
0
0
PAT Margin
18%
16%
16%
19%
17%
17%
16%
20%
19%
21%
24%
PAT Growth
40%
-1%
-8%
11%
14%
9%
-13%
16%
-11%
1%
 
EPS
14.09
10.05
10.17
11.02
9.89
8.66
7.91
9.07
7.84
8.82
8.72

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Shareholder's Funds
1,445
1,276
1,270
1,082
936
845
784
695
616
527
Share Capital
18
18
18
18
18
18
18
18
19
19
Total Reserves
1,428
1,259
1,252
1,065
919
827
766
677
598
508
Non-Current Liabilities
229
211
217
20
24
31
31
30
30
29
Secured Loans
0
0
0
0
0
0
0
1
1
1
Unsecured Loans
0
1
1
1
1
1
1
1
2
4
Long Term Provisions
214
194
199
0
1
0
0
0
2
0
Current Liabilities
497
480
389
163
188
196
154
139
123
124
Trade Payables
78
97
75
83
87
80
61
58
46
43
Other Current Liabilities
62
69
64
50
37
43
36
30
30
37
Short Term Borrowings
0
0
0
0
1
1
1
1
1
0
Short Term Provisions
358
314
250
31
63
72
56
50
47
44
Total Liabilities
2,172
1,968
1,876
1,266
1,148
1,072
970
865
769
679
Net Block
682
674
678
675
393
284
289
293
277
256
Gross Block
818
776
746
709
630
470
453
430
396
359
Accumulated Depreciation
136
103
68
34
237
186
164
137
119
103
Non Current Assets
1,113
977
958
742
646
619
558
418
322
285
Capital Work in Progress
12
13
6
20
29
18
7
11
10
30
Non Current Investment
179
74
54
39
217
187
245
96
14
0
Long Term Loans & Adv.
239
215
218
8
6
129
15
17
19
0
Other Non Current Assets
1
1
1
0
1
1
2
1
2
0
Current Assets
1,058
991
918
523
502
452
411
446
447
394
Current Investments
406
397
437
285
272
230
171
244
249
229
Inventories
174
160
137
131
123
103
100
103
97
90
Sundry Debtors
88
82
76
62
61
59
43
42
41
37
Cash & Bank
21
29
28
18
15
23
36
17
18
17
Other Current Assets
370
11
10
7
30
36
60
41
42
21
Short Term Loans & Adv.
359
312
230
20
15
28
49
35
40
21
Net Current Assets
561
511
529
360
314
256
257
307
323
270
Total Assets
2,172
1,968
1,876
1,266
1,148
1,072
970
865
769
679

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Cash From Operating Activity
112
150
154
174
128
150
150
144
121
169
PBT
238
241
258
232
204
218
198
172
175
181
Adjustment
-3
0
-11
2
-1
-8
-14
-3
1
-6
Changes in Working Capital
-48
-23
-19
-5
-12
7
4
9
-21
21
Cash after chg. in Working capital
186
218
228
230
190
218
188
179
156
195
Interest Paid
0
0
0
0
0
0
0
0
0
0
Tax Paid
-74
-68
-70
-56
-63
-68
-38
-34
-35
-27
Other Direct Exp. Paid
0
0
0
0
0
0
0
0
0
0
Extra & Other Items
0
0
-3
0
0
0
0
0
0
0
Cash From Investing Activity
-120
20
-144
-73
-89
-55
-107
-108
-33
-127
Net Fixed Assets
-41
-37
-24
-82
-170
-28
-20
-26
-18
-30
Net Investments
-114
20
-166
170
-72
-1
-76
-83
-34
-118
Others
34
37
47
-162
154
-26
-12
1
18
21
Cash from Financing Activity
0
-169
0
-97
-48
-75
-63
-58
-58
-37
Net Cash Inflow / Outflow
-8
1
11
4
-9
19
-20
-22
30
4
Opening Cash & Equivalents
28
27
16
12
23
4
24
46
16
12
Closing Cash & Equivalent
20
28
27
16
15
23
4
24
46
16

Financial Ratios

Consolidated /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Book Value (Rs.)
83
73
71
61
53
47
43
38
33
28
ROA
8%
9%
12%
14%
13%
13%
17%
16%
21%
24%
ROE
13%
14%
16%
17%
17%
17%
21%
20%
26%
31%
ROCE
18%
19%
22%
23%
23%
27%
27%
26%
31%
38%
Fixed Asset Turnover
1.37
1.42
1.44
1.52
1.65
1.87
1.79
1.75
1.91
1.86
Receivable days
28
27
24
22
24
22
20
21
20
20
Inventory Days
56
50
47
46
45
43
47
51
47
53
Payable days
40
41
41
45
48
44
40
37
33
34
Cash Conversion Cycle
44
35
30
23
22
20
26
34
34
39
Total Debt/Equity
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.01
0.01
0.01
Interest Cover
167
173
180
167
113
71
124
123
123
126

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.